Myasthenia Gravis

2 Items

Set Descending Direction
  1. Generic: Neostigmine Bromide
    Equivalent Brand: Prostigmin
    30 Tablet/s
  2. Generic: Pyridostigmine
    Equivalent Brand: Mestinon
    30 Tablet/s
per page

Myasthenia gravis is a chronic autoimmune neuromuscular disorder characterized by muscle weakness and fatigue. This condition occurs when the immune system mistakenly attacks and impairs the communication between nerves and muscles. The hallmark feature of myasthenia gravis is muscle weakness that worsens with activity and improves with rest. Here's an overview of myasthenia gravis, its symptoms, causes, diagnosis, and treatment:

Symptoms of Myasthenia Gravis:

1. Muscle Weakness:

  • Weakness, often starting in the face and eye muscles, including difficulty with facial expressions and eyelid drooping (ptosis).

2. Fatigue:

  • Weakness increases with repeated muscle use and improves with rest.

3. Double Vision (Diplopia):

  • Difficulty coordinating eye movements, leading to double vision.

4. Difficulty Swallowing (Dysphagia):

  • Weakened muscles in the throat can cause difficulty in swallowing.

5. Speech Difficulties:

  • Weakness in the muscles involved in speech may result in slurred speech.

6. Muscle Fatigue:

  • Symptoms worsen as the day progresses and with increased physical activity.

Causes and Pathophysiology:

1. Autoimmune Reaction:

  • Myasthenia gravis is primarily caused by an autoimmune response where the body produces antibodies that target acetylcholine receptors at the neuromuscular junction.

2. Thymus Involvement:

  • The thymus gland, which plays a role in the immune system, is often abnormal in individuals with myasthenia gravis. Some may have a thymoma (a tumor of the thymus).


1. Clinical Evaluation:

  • Based on symptoms and physical examination.

2. Edrophonium Test:

  • A short-acting medication (edrophonium) is administered to temporarily improve muscle strength, helping in the diagnosis.

3. Blood Tests:

  • Checking for the presence of specific antibodies related to myasthenia gravis.

4. Electromyography (EMG):

  • Measures electrical activity in muscles and can help identify neuromuscular transmission abnormalities.

5. Imaging Studies:

  • CT scans or MRI may be performed to assess the thymus gland.

Treatment Approaches:

1. Medications:

  • Cholinesterase Inhibitors: Drugs like pyridostigmine enhance the communication between nerves and muscles.
  • Immunosuppressants: Medications such as corticosteroids or other immunosuppressive drugs may be prescribed to suppress the autoimmune response.

2. Thymectomy:

  • Surgical removal of the thymus gland, particularly if a thymoma is present.

3. Plasma Exchange (Plasmapheresis):

  • A procedure to remove antibodies from the blood.

4. Intravenous Immunoglobulin (IVIG):

  • Infusions of immunoglobulins to modify the immune response.

Lifestyle Management:

1. Conserving Energy:

  • Managing activities to avoid excessive fatigue.

2. Speech and Swallowing Therapy:

  • Working with speech therapists to address speech and swallowing difficulties.

3. Regular Follow-up:

  • Monitoring symptoms and adjusting treatment as needed.


Myasthenia gravis is a chronic condition that requires ongoing management. With appropriate treatment, many individuals with myasthenia gravis can lead fulfilling lives. Early diagnosis and a comprehensive treatment plan, often involving a multidisciplinary team of healthcare professionals, are essential for optimizing outcomes. If you suspect you or someone you know may have myasthenia gravis, seeking prompt medical evaluation is crucial for accurate diagnosis and timely intervention.